Skip to main content

Inspection Machines Market To Reach USD 871 Million By 2025 - Growing Demand For Personalized Medicine

 What This Report Will Provide?

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Expected Revenue Growth:

The Inspection machines market is projected to reach USD 871 million by 2025 from USD 671 million in 2020, at a CAGR of 5.4% during the forecast period.

Major Growth Boosters:

The growth of this market is majorly driven as companies are now increasingly adopting inspection systems throughout their production lines due to the growing concerns to the regulatory mandates introduced by the government and regulatory bodies in the healthcare industry to maintain compliance with Good Manufacturing Practices (GMP).

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81453085 

COVID-19 Impact on the Inspection Machines Market

Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This had disrupted the supply chains for the inspection machines market, temporarily leading to a fall in demand due to uncertainty in the global economy and capital markets.

Recent Developments :

  • In 2020, Antares partnered with IMA; a company engaged in the design & production of machines for process automation and packaging of pharmaceutical & cosmetic products.
  • In 2019, METTLER-TOLEDO International Inc. launched their Tablet-Pro metal detection systems.
  • In 2019, Cognex Corporation launched the DSMax32T laser displacement 3D system.
  • In 2019, ACG Inspection opened a new Centre of Excellence in Switzerland.

Growing number of regulatory mandates to maintain compliance with GMP in the healthcare industry

Regulatory agencies, such as the Food and Drug Administration (US), European Medicines Agency, and the Pharmaceuticals and Medical Devices Agency (Japan), ensure the quality of drugs and medical devices by carefully monitoring the compliance of manufacturers with Current Good Manufacturing Practice (CGMP) regulations. CGMP regulations for drugs and medical devices contain minimum requirements for the methods, facilities, and controls used in manufacturing, processing, and packing them. The regulations that have been implemented ensure that products are safe for use and have the ingredients and strength they claim to have.

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=81453085 

Regional Growth Analysis:

In 2019, North America accounted for the largest share of the inspection machines market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the significant growth opportunities for players operating in the inspection machines market owing to the presence of a large number of pharmaceutical and biotechnology companies & medical device manufacturers in the region, stringent regulatory mandates for healthcare manufacturers, an increasing number of inspection checkpoints in the production line, and highly regulated inspection standards & obligatory compliance in the region.

Comments

Popular posts from this blog

Medical Device Reprocessing Market – Statistics and Growth Dynamics To 2022

  Expected Revenue Growth: The  global medical device reprocessing market  is projected to be valued at USD 823.5 Million in 2017 and is expected to grow at a CAGR of 16.3% during the forecast period to reach to USD 1,754 Million by 2022. Base year considered for the report is 2016. What This Report Will Provide? The growth of this market is majorly driven by the increased utilization of the low priced reprocessed medical devices as compared to new devices, increased efforts towards reducing regulated medical waste (RMW), and rising number of surgical procedures associated with the growing prevalence of chronic diseases. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent. Major Growth Boosters: The medical device reprocessing includes cleaning, disinfection, inspection, sterilization, and repackaging of used medical devices for its reuse to diagnose and treat ...

Aesthetic/Cosmetic Lasers Market Worth USD 1,132.7 Million (At A CAGR Of 10.2%)

  Increasing preference for noninvasive cosmetic procedures, increasing disposable income, technological advancements, and rising medical tourism are the major drivers of the aesthetic lasers market. However, lack of reimbursement will restrain the growth of this market. What This Report Will Provide? Factors such as multiplatform lasers provide clinicians the flexibility and versatility of several standalone systems in a single package, and provide combination therapy to synergistically treat a single indication or provide treatment addressing multiple elements of any indication is contributing to the high growth of this segment in the forecast period. Expected Revenue Growth: The global  aesthetic lasers market  is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021. Major Growth Boosters: Growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and ...

Autoinjectors Market | Newest Industry Data, Future Trends and Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs. The  global autoinjectors market  is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). In terms of Therapy, the global autoinjectors market can be segmented into: Rheumatoid Arthritis Multiple Sclerosis Diabetes Anaphylaxis Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia) By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018 On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therap...